The dangerous and dominant Covid-19 Variant: What we need to know? | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
May 30, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, MAY 30, 2025
The dangerous and dominant Covid-19 Variant: What we need to know?

Panorama

Safen Roy
16 April, 2021, 11:20 am
Last modified: 16 April, 2021, 11:29 am

Related News

  • Govt plans to relocate country's first vaccine plant from Gopalganj to Munshiganj
  • Umrah pilgrims struggle with abrupt meningitis vaccination requirement amid shortage
  • Vaccination, early screening can prevent cervical cancer death for women
  • Study on Bangladeshi children confirms lasting impact of typhoid vaccine
  • No doctor necessary: US okays nasal spray flu vaccine for self-use

The dangerous and dominant Covid-19 Variant: What we need to know?

In the latest interview with The Business Standard, noted microbiologist Dr Bijon Shil, developer of the first Covid-19  rapid test kit for Bangladesh, talks about the new variants of Covid, how to stay safe, vaccine and treatment protocols. 

Safen Roy
16 April, 2021, 11:20 am
Last modified: 16 April, 2021, 11:29 am
Dr Bijon Kumar Shil. Illustration: TBS
Dr Bijon Kumar Shil. Illustration: TBS

Dr Bijon Kumar Shil, in the last interview, had predicted correctly "If a second strain of the virus emerges like that in the UK and Africa, that could be a potential threat for herd immunity because of people's exposure to the new strain of the virus and/or the vaccination itself." 

This very situation is evident at present and is a backtrack for Bangladesh as well as the world from reaching pre-pandemic conditions.

What should people know about this new dominant South African variant (B.1.351)? Is it more contagious, and is it more deadly? 

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Let's talk about these variants; there are three categories of variants. The first one is Variants of Interest (VOI), which have a specific genetic markup; these variants are associated with high transmission, case fatalities,  reduced treatment efficacy, and potential diagnostic problems. However, these are all under investigation and not confirmed. Under the VOI, a few identified are B.1.526, B.1.525, and P2 from Brazil.

The second group is called the Variant of Concern (VOC); they have strong evidence of increased transmissibility and the ability to cause severe diseases, hospitalisation, and mortality. VOCs also can overcome immunity generated by previous infections or vaccinations. Among the VOC are B.1.1.7, which was identified in Britain in September 2020.  The other variant, P1, was isolated in Brazil; the third one is B1.351, which originated from Africa and is currently prevailing in Bangladesh. VOCs can break through the immune belt and as well as vaccination and are much harder to diagnose. 

The third one is the most critical Variant of High Consequence; luckily, this strain of viruses has not been identified yet. icddr, b detected B.1.1.7 in January 2021. But after March, the dominant strain in Bangladesh became  B1.351. So the question is, what happened to B.1.1.7? The reason may be that the antibodies developed by infection and vaccination wiped out the B.1.1.7 variant. 

As most Bangladeshi might already have antibodies against B.1.1.7, it stopped the virus's further spread. Unfortunately, the African strain B1.351 can break the immune system. One study found that 40 out of 100 people, if exposed to this strain, ultimately failed to protect themselves against this variant and have severe health problems. At the same time, the other 60 people will also develop minor health risks. There is a risk for a large portion of people in Bangladesh to contract the virus.

With the new strain (B.1.351) of the Covid-19 virus, what is your recommendation for people to stay safe?

At this moment, the only recommendation is to prevent the transmission of the virus by using masks. Because the mask is the only means to break the virus's cycle jumping from one person to another, it is still important to maintain other healthy practices like social distancing, washing and sanitising hands, and avoid going out unless it's urgent. If you have to, I think the priority should be to wear masks.

People can also take some Vitamin C (1000mg) per day. People can use locally available sanitiser, while antiseptic like neem and alum in warm water can be used for mouthwash. 

In some parts of the world, especially the UK, there are reports of people having blood clots from AstraZeneca vaccine? Should Bangladeshi people also be worried?

One of the major concerns is blood clots from the AstraZeneca Vaccine, though the numbers are very low. The reason why it is happening is unknown right now and under investigation. If you want to protect most of the population, it's best to go for vaccination as reports show only 80 people out of 35 million have blood clots. So it's a minimal number: even the European Medical Association and the WHO has recommended the continuation of vaccine use.

What would you comment about the management of the spread of Covid-19 in March? What do you think has led to a higher number? Is it something to do with no lockdowns, less social distancing, or any other reason?

People are reluctant to follow the rules and regulations, and they are reckless with their behaviour.  Bangladesh was almost close to eliminating the virus, and for two months, the infection rate was almost 2% after vaccination, before the new variant came. There are also people going to the tourist areas, causing the virus's new strain to be transmitted more.

With the Shortage of ICUS and healthcare for many people, what do you recommend at this time?

The most important thing to do if anyone has symptoms like a headache or rashes is to inform the family members and become isolated. The suspected person and the family members should wear a mask. They should take Covid -19 tests as soon as possible. Trying to limit the spread of the virus is very important. Also, they should clean their homes with antiseptic. They can also increase and alert the immune system by taking Vitamin C. Lastly, if people think they have any symptoms, they should also inform doctors and respective authorities.

Bangladesh has received vaccines from India, but they have stopped exporting vaccines due to the surge in Indian cases. In this case, should we have also imported the Sinovac, Sputnik, or other vaccines? And should we try now to import?

India is showing one of the highest infection rates globally, and in this case, they will try to protect their population. But Bangladesh can import vaccines from other countries. But at the moment, the virus will continue to mutate. We might have to handle it and might have to live with it. So the best course of action in the long term is to develop our vaccines using dominated variants of SARSCoV2. If we develop our vaccines, we are more protected from local strains, and it's more viable for the country.

Should the treatment protocol be different with the new strain from that from before? Based on a recent TBS report, doctors voiced that the old protocol is not working. 

I am sure Bangladeshi doctors are familiar with the new strain. I know doctors working with the patients and are doing their best in diagnosing and treating them. I am sure they can manage it. I cannot suggest any protocols but just recommend social distancing procedures, taking Vitamin C, and wearing masks for people. The viral disease has no specific treatment, and patients are treated based on their symptoms. Bangladeshi doctors are very good at diagnosing and treating when the situation arises.

Do you still think for us to go to a pre-pandemic situation, and if so, what would you say the time frame is for that?

It is very tough now. Last year, in July, I said Bangladesh could have eradicated the virus by January or February 2021. But it was impossible because of the new strain, even if people have antibodies and vaccines. The virus can mutate again and again, and in the future, mutations might come even faster than the last time. At present, It is still tough to go back to the pre-pandemic stage. 

We live in a Global Village, so a single country cannot eradicate the disease alone and be isolated if the whole world's population is at risk. If the world's population were to use masks for 120 days, the virus would be contained because it cannot live outside living beings. Then we can see the infection rates go down. Even if we use vaccines or use treatment, lockdown, or restrictions, it may not affect us in the short term.

Masks may be the only way to eradicate Covid-19 from the world. National and international bodies should spread awareness of wearing masks. In 2003, we contained the SARS-CoV-1 by wearing masks, not by the vaccine. We need to understand the importance of these measures. In a way, masks are the universal Vaccine that can protect whatever variants are circulating and will develop in the future.

Features / Interviews / Top News / Covid-19 in Bangladesh

COVID-19 in Bangladesh / Dr Bijon Kumar Shil / Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Chief Adviser Muhammad Yunus during a question-answer session at the 30th Nikkei Forum in Tokyo, Japan on Thursday, 29 May 2025. Photo: CA Press Wing
    Just one particular party wants election in December: CA Yunus
  • Two people move furnitures as continuous rain causes waterlog in Dhaka road on Thursday, 29 May 2025. Photo: Collected
    Land depression moves over Tangail, rough weather likely to persist
  • Chief Adviser Muhammad Yunus meets Japanese Prime Minister Ishiba Shigeru in Japan on 30 May 2025. Photo: CA Office
    Japan's PM reiterates full support for CA's reform initiatives

MOST VIEWED

  • Photo: Courtesy
    New notes featuring historic, archaeological structures of Bangladesh to be circulated from 1 June
  • Two Memoranda of Understanding were signed at the seminar titled “Bangladesh Seminar on Human Resources,” in Tokyo on 29 May 2025. Photo: CA Press Wing
    Japan to recruit 100,000 Bangladeshi workers over next 5 years
  • Representational Photo: Collected
    Country's all jewellery shops to remain indefinitely closed in protest of VP Reponul's arrest: Bajus
  • BAT Bangladesh has to vacate Mohakhali HQ as SC rejects lease appeal
    BAT Bangladesh has to vacate Mohakhali HQ as SC rejects lease appeal
  • Illustration: TBS
    Bangladesh repays $3.5b foreign debt in 10 months of FY25
  • Khondoker Rashed Maqsood. File Photo: Collected
    Investors urge removal of BSEC chairman in meeting with CA’s special assistant, submit list of demands

Related News

  • Govt plans to relocate country's first vaccine plant from Gopalganj to Munshiganj
  • Umrah pilgrims struggle with abrupt meningitis vaccination requirement amid shortage
  • Vaccination, early screening can prevent cervical cancer death for women
  • Study on Bangladeshi children confirms lasting impact of typhoid vaccine
  • No doctor necessary: US okays nasal spray flu vaccine for self-use

Features

Photo collage of the sailors and their catch. Photos: Shahid Sarkar

Between sky and sea: The thrilling life afloat on a fishing ship

1h | Features
For hundreds of small fishermen living near this delicate area, sustainable fishing is a necessity for their survival. Photo: Syed Zakir Hossain

World Ocean Day: Bangladesh’s ‘Silent Island’ provides a fisheries model for the future

18h | The Big Picture
The university will be OK. But will the US? Photo: Bloomberg

A weaker Harvard is a weaker America

18h | Panorama
The Botanical Garden is a refuge for plant species, both native and exotic. Photo: Mehedi Hasan/TBS

The hidden cost of 'development' in the Botanical Garden

18h | Panorama

More Videos from TBS

Record migrant deaths in 2024

Record migrant deaths in 2024

15h | Podcast
News of The Day, 29 MAY 2025

News of The Day, 29 MAY 2025

17h | TBS News of the day
Businesses set for relief as interim govt eyes major tax & fine cuts

Businesses set for relief as interim govt eyes major tax & fine cuts

19h | TBS Insight
Love is essential for human life

Love is essential for human life

19h | TBS Programs
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net